Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jenner

Showing results (501-510 of 548) with videos related to

Pageof 55
Sort By:
European Journal of Pharmacology|December 15, 1992
A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosetsJ W Kebabian, D R Britton, M P DeNinno, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 20, 2023
Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson's diseaseP Jenner, C Falup-Pecurariu, V Leta, et al.
Biochemical Pharmacology|September 7, 1995
Inhibition of monoamine oxidase by isoquinoline derivatives. Qualitative and 3D-quantitative structure-activity relationshipsU Thull, S Kneubühler, P Gaillard, et al.
Experimental Neurology|October 17, 2009
Continuous rotigotine administration reduces dyskinesia resulting from pulsatile treatment with rotigotine or L-DOPA in MPTP-treated common marmosetsK A Stockwell, D K A Scheller, L A Smith, et al.
Brain Research|March 20, 1999
Expression and localisation of CYP2D enzymes in rat basal gangliaA G Riedl, P M Watts, R J Edwards, et al.
Neuroreport|September 8, 1994
Nigral dopaminergic cell loss in vitamin E deficient ratsD T Dexter, I Nanayakkara, M A Goss-Sampson, et al.
European Journal of Neurology|September 3, 2009
Perspectives on recent advances in the understanding and treatment of Parkinson's diseaseA H Schapira, Y Agid, P Barone, et al.
Journal of Neurochemistry|September 1, 1997
Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigraZ I Alam, A Jenner, S E Daniel, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1987
The influence of aromatic substituents on the binding of substituted benzamides to dopamine D-2 receptors: congruent QSAR and MEP analysesB Testa, N el Tayar, P A Carrupt, et al.
Neuroscience|January 9, 1999
Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylaseP M Watts, A G Riedl, D C Douek, et al.
Pageof 55

Showing results (501-510 of 548) with videos related to

Sort By:
Pageof 55
European Journal of Pharmacology|December 15, 1992
A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosetsJ W Kebabian, D R Britton, M P DeNinno, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 20, 2023
Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson's diseaseP Jenner, C Falup-Pecurariu, V Leta, et al.
Biochemical Pharmacology|September 7, 1995
Inhibition of monoamine oxidase by isoquinoline derivatives. Qualitative and 3D-quantitative structure-activity relationshipsU Thull, S Kneubühler, P Gaillard, et al.
Experimental Neurology|October 17, 2009
Continuous rotigotine administration reduces dyskinesia resulting from pulsatile treatment with rotigotine or L-DOPA in MPTP-treated common marmosetsK A Stockwell, D K A Scheller, L A Smith, et al.
Brain Research|March 20, 1999
Expression and localisation of CYP2D enzymes in rat basal gangliaA G Riedl, P M Watts, R J Edwards, et al.
Neuroreport|September 8, 1994
Nigral dopaminergic cell loss in vitamin E deficient ratsD T Dexter, I Nanayakkara, M A Goss-Sampson, et al.
European Journal of Neurology|September 3, 2009
Perspectives on recent advances in the understanding and treatment of Parkinson's diseaseA H Schapira, Y Agid, P Barone, et al.
Journal of Neurochemistry|September 1, 1997
Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigraZ I Alam, A Jenner, S E Daniel, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1987
The influence of aromatic substituents on the binding of substituted benzamides to dopamine D-2 receptors: congruent QSAR and MEP analysesB Testa, N el Tayar, P A Carrupt, et al.
Neuroscience|January 9, 1999
Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylaseP M Watts, A G Riedl, D C Douek, et al.
Pageof 55